EX-10.1
from 10-K
>50
pages
Kevin A. Lobo Chair and CEO Personal and Confidential February 4, 2026 First Name Last Name Dear First Name, I Am Pleased to Inform You That You Are One of a Select Group of Individuals Receiving a Stock Option Award in 2026. We Use These Awards to Reward Performers Who We Believe Will Be Key Contributors to Our Growth Well Into the Future. the Total Award Date Value (Adv) of Your Award Is Approximately Usd $Xx,xxx. We Are Awarding You a Nonstatutory Stock Option for XXX Shares of Stryker Corporation Common Stock at a Price of Usd $XXX.XX Per Share. Except as Otherwise Provided in the Terms and Conditions, You May Exercise This Option at 20% Per Year Beginning on February 4, 2027, and It Will Expire on February 3, 2036. You Must “Accept” the Award Online via the Ubs One Source Web Site Located at WWW.UBS.com/ Onesource/SYK Between March 3 and March 31, 2026. the Detailed Terms of the Option Are in the Terms and Conditions, Any Applicable Country Addendum and the Provisions of the Company's 2011 Long- Term Incentive Plan, as Amended and Restated. Those Documents, Together With the Related Prospectus, Are Available on the Ubs One Source Web Site, and You Should Read Them Before Accepting the Award. in Addition, You May Be Asked to Sign the Most Recent Version of Stryker’s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (“Non-Compete Agreement”) in Connection With This Award. if You Are Asked to Sign the Non-Compete Agreement, It Will Be Emailed to You and You Will Be Asked to Sign the Document Electronically via Adobe Sign by March 31, 2026. the Exercisability of the Options Is Conditioned on You Having Signed the Non-Compete Agreement by March 31, 2026, Where Permitted by Applicable Law. You Can Find Additional Educational Materials on the Ubs One Source Web Site in the Resources Section, Including Stock Option Brochure and Stock Option Tax Questions & Answers. Sincerely, Stryker Corporation
12/34/56
EX-10.2
from 8-K
2 pages
Spencer S. Stiles Group President, Orthopaedics December 2, 2025 Dylan Crotty Subj: Promotion and Compensation Changes Dear Dylan, It Is With Pleasure That I Confirm Your Promotion to Group President, Orthopaedics, Effective January 1, 2026. a Summary of the Compensation Package Related to Your New Role Is as Follows: Annualized Base Salary and Bonus Target
12/34/56
EX-10.2
from 8-K
2 pages
Kevin A. Lobo Chair and CEO January 27, 2025 Preston Wells Subj: Promotion and Compensation Changes Dear Preston, It Is With Pleasure That I Confirm Your Promotion to Vice President, Chief Financial Officer, Effective April 1, 2025. a Summary of the Compensation Package Related to Your New Role Is as Follows: Annualized Base Salary and Bonus Target • Your Annualized Base Salary Will Increase to $725,000. • This Pay Increase Will Be Effective April 1, 2025. • Your Annualized Bonus Target Will Be $616,250 (85% of Your Annualized Base Salary). Your Bonus in 2025 Will Be Prorated Based on the Effective Date of This Position Change. • You Are Scheduled to Receive a Performance Review in February 2026, and You Are Eligible for a Merit Increase in March 2026 Based Upon Your Performance. Subsequent Reviews Will Be Conducted Annually. 2025 Stock Award
12/34/56
